Synaptogenix Inc (SNPX)

[Rubyred77]

Hi NTRP shareholders,
I'd have to agree with blu_1. I've been following AVXL for the last 2 years and they have given nothing but positive results. Although I am rooting for any Alz clinical trial to succeed, most likely you will end up bag holders.
Looking at the IIa trial of NTRP and I have questions such as
1. why are they trying to rush a experimental drug through as if time is
of the essence.
2. Why only 9 participants 6 on Bryo 3 on placebo
3. How is it that placebo could cause these results out of 3 patients,
yet no complaints about any besides a headache for Bryo?

Dizziness 0 1
Headache 1 1
Rash Papular 0 1


Then on the p2,

1. Why only run the trials for 12 weeks, while everyone knows that OVER
TIME, they deteriorate?
2. Principle investigator is a Kenneth Gorelick. Isn't that the same name as Kenny G the saxaphone player? No disrespect, just a lol office space moment.

3. How can kenneth be the priciple investigator and hold shares of the company he is investigating the drug for?

http://www.marketwatch.com/investing/Stock/NTRP/insiders?pid=147413954

It is the number one reason why P3 trials fail, besides the drug being a placebo. Im open to a civilized discussion as I would gladly invest in NTRP if I have faith in the Management.